Table 2.

Patient characteristics (preeclampsia vs control)

Author; Date	Patients number	Maternal age (years)	Gestational age (weeks)			AMH levels
Agabain; 2017	40 vs 40	27.7 ± 6.9vs 29.5 ± 6.7		36.7 vs 36.9	0.700(0.225–1.500) vs 0.700 (0.400–1.275)ng/ml
Tokmak; 2014	45 vs 42	28.7 ± 6.2 vs 27.0 ± 4.2		34.0 ± 3.5 vs 38.1 ± 2.6	0.62 ± 0.51 vs 0.93 ± 0.83 ng/ml ¥
Birdir;2014	50 vs 150	32.6 (29.4–37.1) vs 31.9 (26.9–35.9)		12.6 (12.3–12.9) vs 12.8 (12.3–13.1)	2.140 (1.968–2.273) vs 2.062 (1.938–2.181) ng/L ¥
Shand; 2014	11 vs 23*	N/A		N/A	4.7 (1.8–13.2) vs 5.5 (1.4–16.1) pmol/L ¥

^* The control group had gestational hypertension;

^¥ results were statistically significant (p<.05)